| 000 | 02846nam a22004935i 4500 | ||
|---|---|---|---|
| 001 | 978-4-431-54049-6 | ||
| 003 | DE-He213 | ||
| 005 | 20140220082926.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 130228s2013 ja | s |||| 0|eng d | ||
| 020 |
_a9784431540496 _9978-4-431-54049-6 |
||
| 024 | 7 |
_a10.1007/978-4-431-54049-6 _2doi |
|
| 050 | 4 | _aRC254-282 | |
| 072 | 7 |
_aMJCL _2bicssc |
|
| 072 | 7 |
_aMED062000 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.994 _223 |
| 100 | 1 |
_aTakami, Hiroshi. _eeditor. |
|
| 245 | 1 | 0 |
_aTreatment of Thyroid Tumor _h[electronic resource] : _bJapanese Clinical Guidelines / _cedited by Hiroshi Takami, Yasuhiro Ito, Hitoshi Noguchi, Akira Yoshida, Takahiro Okamoto. |
| 264 | 1 |
_aTokyo : _bSpringer Japan : _bImprint: Springer, _c2013. |
|
| 300 |
_aXVIII, 310 p. 16 illus., 9 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 520 | _aCreating clinical guidelines is a modern trend. Published studies pertaining to a given theme are collected, their credibility evaluated, and then treatment options in the form of evidence-based guidelines are offered. There are a number of guidelines for the treatment of thyroid tumors that have established positions in clinical practice in North America and in Western European countries. In Japan, however, where radioisotope facilities are of limited availability, treatment plans for differentiated thyroid cancer differ considerably from those of America and Europe, and the associated clinical guidelines need modification before they can be adopted. In addition, although thyroid tumor is a common disease in endocrine practice, its management can differ even among specialists. Thus, a Japanese clinical guideline for the treatment of thyroid tumor was desired by many clinicians. As a combination of evidence-based and consensus-based guidelines for the treatment of thyroid tumor, this book offers alternatives to conventional approaches in the West. Ultimately, the authors hope the guideline will lead to the best possible treatment for patients all over the world in the not-distant future. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aEndocrinology. | |
| 650 | 0 | _aOncology. | |
| 650 | 0 | _aSurgery. | |
| 650 | 1 | 4 | _aMedicine & Public Health. |
| 650 | 2 | 4 | _aOncology. |
| 650 | 2 | 4 | _aEndocrinology. |
| 650 | 2 | 4 | _aSurgery. |
| 700 | 1 |
_aIto, Yasuhiro. _eeditor. |
|
| 700 | 1 |
_aNoguchi, Hitoshi. _eeditor. |
|
| 700 | 1 |
_aYoshida, Akira. _eeditor. |
|
| 700 | 1 |
_aOkamoto, Takahiro. _eeditor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9784431540489 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-4-431-54049-6 |
| 912 | _aZDB-2-SME | ||
| 999 |
_c99036 _d99036 |
||